B Séguin, B Hardy, PA Singer, AS Daar - Pharmacogenomics Journal- …, 2008 - pharmalot.com 1Program on Life Sciences, Ethics and Policy, McLaughlin-Rotman Centre for Global
Health, University Health Network/McLaughlin Centre for Molecular Medicine at University of
Toronto, MaRS Centre, South Tower, Toronto, Ontario, Canada; 2Leslie Dan Faculty of ... Cited by 5 - Related articles - View as HTML - BL Direct - All 4 versions
- ►berkeley.edu [PDF] DE Winickoff, OK Obasogie - Trends in Pharmacological Sciences, 2008 - Elsevier Numerous articles and commentaries in the health literature recently have questioned the emergence
of race as an increasingly powerful organizing principle in clinical medicine and pharmaceutical
development [1] and [2]. Yet proposals for regulatory reform remain thin. Debate over ... Cited by 2 - Related articles - All 3 versions
KL Rice, I Leimer, S Kesten, DE Niewoehner - Translational Research, 2008 - Elsevier Sparse information exists about chronic obstructive pulmonary disease (COPD) outcomes among
different ethnic groups. To determine whether the effect of tiotropium on COPD exacerbation
differs between African Americans and Caucasians, we performed a post hoc analysis of ... Cited by 1 - Related articles - All 9 versions
GTH Ellison, JS Kaufman, RF Head, PA … - The Journal of law, …, 2008 - pubmedcentral.nih.gov Kirsten Bibbins-Domingo and Alicia Fernandez published a response to the article by Temple
and Stockbridge, 14 but for the most part, they did not address these methodological or ethical
concerns. Instead, their response focused on the way the FDA the need to address racial ... Cited by 1 - Related articles - All 10 versions
PW ROCHE, JD MED - ensp.unl.pt Racial classifications are increasingly being used in the development and marketing of drugs
by pharmaceutical companies that portray their products as necessary tools for reducing health
disparities among racial and ethnic groups in the United States. Significant gaps in the ... View as HTML
VL Bonham, T Citrin, SM Modell, TH Franklin, … - Journal of Health …, 2009 - Duke Univ Press Abstract Engaging communities of color in the genetics public policy conver- sation is important
for the translation of genetics research into strategies aimed at improving the health of all. Implementing
model public participation and consulta- tion processes can be informed by the ... Related articles - All 2 versions
FQ Interactions - medscape.com Experts agree that racial and ethnic health disparities are largely a consequence of sociocultural
and socioeconomic differences that increase the risk of disease. [1] Nonetheless, there is much
hope invested in the promise that human genome research will also help reduce racial ... Related articles - All 3 versions
NK Lakdawala, A Desai - axon.es Abstract Heart failure due to a decline in cardiac performance initiates compensatory neurohormonal
mechanisms in an effort to maintain systemic perfusion. Ongo- ing neurohormonal activation
may have deleterious consequences for cardiac performance, ventricular remodeling, ... Related articles - View as HTML
JK Ghali - Journal of cardiac failure, 2007 - Elsevier I read with interest the article by Echols et al on racial differences and their relation to outcome
in Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart
Failure (OPTIME-CHF) trial. 1 The authors state that the results from the African American ... Related articles - All 14 versions
VL Bonham, SL Sellers, TH Gallagher, D Frank, … - Genetics in …, 2009 - journals.lww.com Nadine A. Kasparian, BA (Psych, Hons I), PhD1,2, Bettina Meiser, BAppSc, PhD2,3, Phyllis
N. Butow, MPH, PhD4, Judy M. Simpson, BSc (Stats), PhD5, and Graham J. Mann, FRACP, PhD6 ... Purpose: The aim of this prospective cohort study was to examine uptake and ... Related articles - All 2 versions
